OS Therapies Inc
OSTX1.691USD
-0.059-3.38%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
36.09MMarket Cap
LossP/E TTM
OS Therapies Inc
1.691
-0.059-3.38%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-436.35%-3.44M
-172.58%-2.37M
-286.14%-3.38M
-6.03%-881.19K
-49.87%-641.73K
42.80%-871.16K
---876.57K
---831.05K
55.44%-428.19K
---1.52M
---960.91K
Net income from continuing operations
-165.72%-3.88M
-104.24%-2.99M
-45.58%-2.88M
37.83%-1.56M
21.01%-1.46M
42.61%-1.46M
---1.97M
---2.51M
-35.56%-1.85M
---2.55M
---1.36M
Operating gains losses
0.00%695.00
--1.39K
-100.00%0.00
-13.66%695.00
595.00%695.00
-100.00%0.00
--3.31K
--805.00
--100.00
--805.00
--0.00
Other non-cash items
-135.90%-207.74K
-84.28%33.52K
-65.52%338.29K
-39.15%508.65K
-21.03%578.74K
-78.42%213.24K
--981.14K
--835.93K
194.20%732.84K
--988.01K
--249.09K
Change in working capital
-225.83%-299.26K
-17.55%313.44K
-843.97%-847.86K
-80.06%166.94K
-65.32%237.83K
845.45%380.17K
--113.96K
--837.27K
349.68%685.84K
--40.21K
--152.52K
-Change in prepaid expenses
----
--35.00K
---35.00K
----
----
----
----
----
----
----
----
-Change in other current assets
----
--77.50K
---15.37K
---62.13K
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-436.35%-3.44M
-172.58%-2.37M
-286.14%-3.38M
-6.03%-881.19K
-49.87%-641.73K
42.80%-871.16K
---876.57K
---831.05K
55.44%-428.19K
---1.52M
---960.91K
Investing cash flow
Net cash from continuing investing activities
----
----
--0.00
----
----
---19.00
--0.00
--19.00
----
----
----
Capital expenditures
----
----
--0.00
----
----
----
--0.00
--19.00
----
----
----
Net cash flow from disposal of fixed assets
----
----
--0.00
----
----
---19.00
--0.00
--19.00
----
----
----
Net cash flow from investment products
---150.00K
----
----
----
----
----
----
----
----
----
----
Net cash flow from other investing activities
---23.64K
--0.00
--0.00
----
----
--0.00
--0.00
--0.00
--1.15K
--0.00
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
---173.64K
-100.00%0.00
--0.00
----
----
--19.00
--0.00
---19.00
--1.15K
--0.00
--0.00
Financing cash flow
Cash flow from continuous financing activities
49.79%1.05M
576.69%6.05M
510.38%5.15M
66.81%875.88K
15.10%702.98K
-45.99%894.06K
--843.41K
--525.08K
-33.97%610.77K
--1.66M
--925.00K
Net cash flow from debt Issuance/repayment
-100.00%0.00
-100.00%0.00
-130.30%-250.00K
84.62%900.00K
9.81%851.00K
-43.46%1.07M
--825.00K
--487.50K
-16.22%775.00K
--1.89M
--925.00K
Net cash flow from common stock issuance/repurchase
----
--0.00
--5.23M
----
----
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
--1.05M
--6.05M
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
100.00%0.00
100.00%0.00
835.22%172.14K
-164.17%-24.11K
9.87%-148.02K
25.77%-175.94K
--18.41K
--37.58K
---164.22K
---237.02K
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
49.79%1.05M
576.69%6.05M
510.38%5.15M
66.81%875.88K
15.10%702.98K
-45.99%894.06K
--843.41K
--525.08K
-33.97%610.77K
--1.66M
--925.00K
Net cash flow
Beginning cash balance
14095.08%5.53M
11470.48%1.86M
92.85%94.92K
-71.78%100.23K
-77.27%38.98K
-59.01%16.06K
--49.22K
--355.21K
112.26%171.48K
--39.18K
--80.79K
Current period cash flow changes
-4283.77%-2.56M
15933.78%3.68M
5416.71%1.76M
98.27%-5.31K
-66.66%61.25K
-82.67%22.92K
---33.16K
---305.99K
611.68%183.73K
--132.30K
---35.91K
Ending cash balance
2864.16%2.97M
14095.08%5.53M
11470.48%1.86M
92.85%94.92K
-71.78%100.23K
-77.27%38.98K
--16.06K
--49.22K
691.48%355.21K
--171.48K
--44.88K
Free cash flow
---3.44M
-172.58%-2.37M
-286.14%-3.38M
----
----
42.80%-871.16K
---876.57K
---831.07K
55.44%-428.19K
---1.52M
---960.91K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
